Nucleoside transporter expression profiles in human cardiac tissue show striking individual variability with overall predominance of hENT1

European Journal of Pharmaceutical Sciences

Volumn 41, Issue 5, 2010, Pages 685-691

  Marvi, Melissa ^a   Rose, Jennifer B ^a   Bang, Andrew ^a   Moon, Byung Choo ^b   Pozeg, Zlatko ^b   Ibrahim, Moheb ^b   Peniston, Charles ^b   Coe, Imogen R ^a  

^a YORK UNIVERSITY   (Canada)

^b SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

Author keywords

Adenosine; Cardiovascular; Drug transporters; Drug uptake; Membrane transporters; Nucleoside transporters; Nucleosides; Quantitative RT PCR

Indexed keywords

ADENOSINE; COMPLEMENTARY DNA; MEMBRANE PROTEIN; NUCLEOSIDE TRANSPORTER; RNA;

ADULT; AGED; AORTA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; DRUG TRANSPORT; GENE EXPRESSION; HEART; HEART RIGHT ATRIUM; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; MEMBRANE TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADENOSINE; ADULT; AGED; AORTA; BIOLOGICAL ASSAY; BIOLOGICAL TRANSPORT; CARDIOVASCULAR DISEASES; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; GENE EXPRESSION REGULATION; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MYOCARDIUM; NUCLEOSIDES; RNA, MESSENGER;

EID: 78349313091     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.09.013     Document Type: Article

References (41)

1. Abdulla P., Coe I.R. Characterization and functional analysis of the promoter for the human equilibrative nucleoside transporter gene, hENT1. Nucleosides Nucleotides Nucleic Acids 2007, 26(1):99-110.
2. Archer R.G., Pitelka V., Hammond J.R. Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cells. Br. J. Pharmacol. 2004, 143:202-214.
3. Baldwin S.A., Beal P.R., Yao S.Y.M., King A.E., Cass C.E., Yong J.D. The equilibrative nucleoside transporter family, SLC29. Pflugers Arch. 2004, 447(5):735-743.
4. Baldwin S.A., Yao S.Y.M., Hyde R.J., Ng A.M.L., Foppolo S., Barnes K., Ritzel M.W., Cass C.E., Young J.D. Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J. Biol. Chem. 2005, 280(16):15880-15887.
5. Barnes K., Dobrzynkski H., Foppolo S., Beal P.R., Ismat F., Scullion E.R., Sun L., Tellez J., Ritzel M.W., Claycomb W.C., Cass C.E., Young J.D., Billeter-Clark R., Boyett M.R., Baldwin S.A. Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH. Circ. Res. 2006, 99(5):510-519.
6. Barrett T., Troup D.B., Wilhite S.E., Ledoux P., Rudnev D., Evangelista C., Kim I.F., Soboleva A., Tomashevsky M., Marshall K.A., Phillippy K.H., Sherman P.M., Muertter R.N., Edgar R. NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res. 2009, 37:D5-1518.
7. Beck D.W., Vinters H.V., Moore S.A., Hart M.N., Cancilla P.A. Uptake of adenosine by cultured cerebral vascular smooth muscle cells. J. Neurochem. 1993, 41:939-941.
8. Belhomme D., Peynet J., Florens E., Tibourtine O., Kitakaze M., Menasché P. Is adenosine preconditioning truly cardioprotective in coronary artery bypass surgery. Ann. Thorac. Surg. 2000, 70:590-594.
9. Chaudary N., Shuralyova I., Liron T., Sweeney G., Coe I.R. Transport characteristics of HL-1 cells: a new model for the study of adenosine physiology in cardiomyocytes. Biochem. Cell Biol. 2002, 80:655-665.
10. Chen J., Rinaldo L., Lim S.J., Young H., Messing R.O., Choi D.S. The type 1 equilibrative nucleoside transporter regulates anxiety-like behavior in mice. Genes Brain Behav. 2007, 6(8):776-783.
11. Choi D.S., Cascini M.G., Mailliard W., Young H., Paredes P., McMahon T., Diamond I., Bonci I., Messing R.O. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat. Neurosci. 2004, 7(8):855-861.
12. Damaraju V.L., Damaraju S., Young J.D., Baldwin S.A., Mackey J., Sawyer M.B., Cass C.E. Nucleoside anticancer drugs: the role of nucleoside transporter in resistance to cancer chemotherapy. Oncogene 2003, 22:7524-7536.
13. Damaraju V.L., Elwi A.N., Hunter C., Carpenter P., Santos C., Barron G.M., Sun X., Baldwin S.A., Young J.D., Mackey J.R., Sawyer M.B., Cass C.E. Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney. Am. J. Physiol. Renal Physiol. 2007, 293:F200-F211.
14. Damaraju V.L., Sawyer M.B., Mackey J.R., Young J.D., Cass C.E. Human nucleoside transporters: biomarkers for response to nucleoside drugs. Nucleosides Nucleotides Nucleic Acids 2009, 28:450-463.
15. de Jong J.W., de Jonge R., Keijzer E., Bradamante S. The role of adenosine in preconditioning. Pharmacol. Ther. 2000, 9:141-147.
16. Edgar R., Domrachev M., Lash A.E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002, 30(1):207-210.
17. Eltzschig H.K., Abdulla P., Hoffman E., Hamilton K.E., Daniels D., Schonfeld C., Löffler M., Reyes G., Duszenko M., Karhausen J., Robinson A., Westerman K.A., Coe I.R., Colgan S.P. HIF-1-dependent repression of endothelial equilibrative nucleoside transporter (ENT) in hypoxia. J. Exp. Med. 2005, 202(11):1493-1505.
18. Floyd J.D., Nguyen D.T., Lobins R.L., Bashir Q., Doll D.C., Perry M.C. Cardiotoxicity of cancer therapy. J. Clin. Oncol. 2005, 23:7685-7696.
19. Govindarajan R., Bakken A.H., Hudkins K.L., Lai Y., Casado F.J., Pastor-Anglada M., Tse C.M., Hayashi J., Unadkat J.D. In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and the placenta. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R1809-R1822.
20. Griffith D.A., Jarvis S.M. Nucleoside and nucleobase transport systems in mammalian cells. Biochem. Biophys. Acta. 1996, 1286:153-218.
21. Handa M., Choi D.S., Caldeiro R.M., Messing R.O., Gordon A.S., Diamond I. Cloning of a novel isoform of the mouse NBMPR-sensitive equilibrative nucleoside transporter (ENT1) lacking a putative phosphorylation site. Gene 2001, 262:301-307.
22. Kim H.H., Liao J.K. Translational therapeutics of dipyridamole. Arterioscler. Thromb. Vasc. Biol. 2008, 28:s39-s42.
23. King A.E., Ackley M.A., Cass C.E., Young J.D., Baldwin S.A. Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharmacol. Sci. 2006, 27:416-425.
24. Kong W., Engel K., Wang J. Mammalian nucleoside transporters. Curr. Drug Metab. 2004, 5:63-84.
25. Loffler M., Morote-Garcia J.C., Eltzschig S.A., Coe I.R., Eltzschig H.K. Physiological roles of vascular nucleoside transporters. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1004-1013.
26. Lu H., Chen C., Klaassen C. Tissue distribution of concentrative and equilibrative nucleoside transporters in male and female rats and mice. Drug Metab. Dispos. 2004, 32:1455-1461.
27. Molina-Arcas M., Trigueros-Motos L., Casado J.F., Pastor-Anglada M. Physiological and pharmacological roles of nucleoside transporter proteins. Nucleosides Nucleotides Nucleic Acids 2008, 27:769-778.
28. Morote-Garcia J.C., Rosenberger P., Nivillac N.I., Coe I.R., Eltzschig H.K. HIF-dependent repression of nucleoside transporter ENT2 attenuates mucosal inflammation during intestinal hypoxia. Gastroenterology 2009, 136(2):607-618.
29. Mubagwa K., Flameng W. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc. Res. 2001, 52:25-39.
30. Naydenova Z., Rose J., Coe I.R. Inosine and equilibrative nucleoside transporter 2 (ENT2) contribute to hypoxic preconditioning in the murine cariomyocyte cell line, HL-1. Am. J. Physiol. Heart 2008, 294(6):H2687-H2692.
31. NCBI Gene Expression omnibus database. GEO 2009, GSM or GDS; 422, 596, 1096, 181, 2206 and 82403 (accessed August 2009). http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE.
32. Pastor-Anglada M., Cano-Soldado P., Molina-Arcas, Lostao M.P., Larrayoz I., Martinez-Picado J., Casado F.J. Cell entry and export of nucleoside analogues. Virus Res. 2005, 107:151-164.
33. Pelleg A., Pennock R.S., Kutalek S. Proarrhythmic effects of adenosine: one decade of clinical data. Am. J. Ther. 2002, 9:141-147.
34. Pennycooke M., Chaudary N., Shuralyova I., Zhang Y., Coe I.R. Differential expression of human nucleoside transporters in normal and tumor tissue. Biochem. Biophys. Res. Commun. 2001, 280(3):951-959.
35. Peres E., Levine J.E., Khaled Y.A., Ibrahim R.B., Braun T.M., Krijanovski O.I., Mineishi S., Abidi M.H. Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation. Bone Marrow Transplant. 2010, 45(1):149-152.
36. Rose J.B., Coe I.R. Physiology of nucleoside transporters: back to the future... Physiology 2008, 23:41-48.
37. Rose J.B., Naydenova Z., Bang A., Eguchi M., Sweeney G., Choi D., Hammond J.R., Coe I.R. Equilibrative nucleoside transporter 1 (ENT1) plays an essential role in cardioprotection. Am. J. Physiol. Heart Circ. Physiol. 2010, 298(3):H771-H777.
38. Santini D., Vincenzi B., Fratto M.E., Perrone G., Lai R., Catalano V., Cass C., Ruffini P.A., Spoto C., Muretto P., Rizzo S., Muda A.O., Mackey J.R., Russo A., Tonini G., Graziano F. Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer. J. Cell Physiol. 2010, 223(2):384-388.
39. Wojtal K.A., Eloranta J.J., Hruz P., Gutman H., Drewe J., Staumann A., Beglinger C., Fried M., Kullak-Ublick G.A., Vavricka S.R. Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients. Drug Metab. Dispos. 2009, 37(9):1871-1877.
40. Young J.D., Yao S.Y.M., Sun L., Cass C.E., Baldwin S.A. Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins. Xenobiotica 2008, 38(7-8):995-1021.
41. Zhang J., Visser F., King K.M., Baldwin S.A., Young J.D., Cass C.E. The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs. Cancer Metastasis Rev. 2007, 26:85-110.